Foamix Pharmaceuticals Ltd (FOMX) Reports Positive Results For FDX104 – Shares Soar in Pre-Market
Foamix Pharmaceuticals Ltd (NASDAQ:FOMX) has just reported positive top-line results for their Phase II Study of FDX104 (a topical foam containing 4% doxycycline). The drug’s…
